636 related articles for article (PubMed ID: 34273064)
1. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study.
García-Abellán J; Padilla S; Fernández-González M; García JA; Agulló V; Andreo M; Ruiz S; Galiana A; Gutiérrez F; Masiá M
J Clin Immunol; 2021 Oct; 41(7):1490-1501. PubMed ID: 34273064
[TBL] [Abstract][Full Text] [Related]
2. Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study.
Masiá M; Fernández-González M; Telenti G; Agulló V; García JA; Padilla S; García-Abellán J; Galiana A; Gonzalo-Jiménez N; Gutiérrez F
J Autoimmun; 2021 Sep; 123():102703. PubMed ID: 34303083
[TBL] [Abstract][Full Text] [Related]
3. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
[TBL] [Abstract][Full Text] [Related]
4. Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.
Moradi G; Mohamadi Bolbanabad A; Ahmadi S; Aghaei A; Bahrami F; Veysi A; Nasiri Kalmarzi R; Shokri A; Ghaderi E; Mohsenpour B; Mohammadi A
Int Immunopharmacol; 2021 Sep; 98():107893. PubMed ID: 34174700
[TBL] [Abstract][Full Text] [Related]
5. Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.
Zhang X; Lu S; Li H; Wang Y; Lu Z; Liu Z; Lai Q; Ji Y; Huang X; Li Y; Sun J; Wu Y; Xu X; Hou J
Virol Sin; 2020 Dec; 35(6):820-829. PubMed ID: 33351168
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19.
Chamkhi S; Dhaouadi T; Sfar I; Mokni S; Jebri A; Mansouri D; Ghedira S; Ben Jemia E; Ben Boujemaa S; Houissa M; Aouina H; Ben Abdallah T; Gorgi Y
Int J Immunopathol Pharmacol; 2022; 36():20587384211073232. PubMed ID: 35113728
[TBL] [Abstract][Full Text] [Related]
7. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients.
Peghin M; Palese A; Venturini M; De Martino M; Gerussi V; Graziano E; Bontempo G; Marrella F; Tommasini A; Fabris M; Curcio F; Isola M; Tascini C
Clin Microbiol Infect; 2021 Oct; 27(10):1507-1513. PubMed ID: 34111579
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
Chen Y; Ke Y; Liu X; Wang Z; Jia R; Liu W; Yang C; Jia L; Wang Y; Han L; Xia X; Zhang S; Wang C
J Med Virol; 2021 May; 93(5):2782-2789. PubMed ID: 33085103
[TBL] [Abstract][Full Text] [Related]
9. The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery.
Peghin M; De Martino M; Fabris M; Palese A; Visintini E; Graziano E; Gerussi V; Bontempo G; D'Aurizio F; Biasotto A; Sartor A; Pipan C; Marzinotto S; Curcio F; Bouza E; Isola M; Tascini C
J Clin Microbiol; 2021 Oct; 59(11):e0113821. PubMed ID: 34379530
[TBL] [Abstract][Full Text] [Related]
10. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].
Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M
Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
Zervou FN; Louie P; Stachel A; Zacharioudakis IM; Ortiz-Mendez Y; Thomas K; Aguero-Rosenfeld ME
J Med Virol; 2021 Sep; 93(9):5409-5415. PubMed ID: 33932299
[TBL] [Abstract][Full Text] [Related]
12. Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.
Masiá M; Fernández-González M; Padilla S; Ortega P; García JA; Agulló V; García-Abellán J; Telenti G; Guillén L; Gutiérrez F
EBioMedicine; 2020 Oct; 60():102999. PubMed ID: 32950003
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
[TBL] [Abstract][Full Text] [Related]
15. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
16. Immunologic phenotype of patients with long-COVID syndrome of 1-year duration.
García-Abellán J; Fernández M; Padilla S; García JA; Agulló V; Lozano V; Ena N; García-Sánchez L; Gutiérrez F; Masiá M
Front Immunol; 2022; 13():920627. PubMed ID: 36090973
[TBL] [Abstract][Full Text] [Related]
17. A stronger antibody response in increased disease severity of SARS-CoV-2.
de Oliveira MI; Aciole MR; Neves PAF; Silva VPOE; Silva MPOE; de Lorena VMB; de Araújo PSR
BMC Infect Dis; 2024 Jan; 24(1):17. PubMed ID: 38166763
[TBL] [Abstract][Full Text] [Related]
18. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.
Ao Z; Li Y; Wei J; Jiang J; Wang X; Zhang P; Liu Y; Yu H; Zhu L; Wang X; Hu Q; Duan J; Hu W; Zhang X; Wu G; Guo S
Clin Exp Med; 2021 Aug; 21(3):361-367. PubMed ID: 33543353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
